Turan Alparslan, Karamanlioğlu Beyhan, Memiş Dilek, Usar Pinar, Pamukçu Zafer, Türe Mevlüt
Department of Anaesthesiology, Trakya University Medical Faculty, Edirne, Turkey.
Anesth Analg. 2004 May;98(5):1370-3, table of contents. doi: 10.1213/01.ane.0000108964.70485.b2.
We investigated, in a randomized, placebo-controlled, double-blind study, the efficacy and safety of gabapentin on pain after abdominal hysterectomy and on tramadol consumption in patients. The 50 patients were randomized to receive either oral placebo or gabapentin 1200 mg 1 h before surgery. Anesthesia was induced with propofol and maintained with sevoflurane in 50% N(2)O/O(2) with a fresh gas flow of 2 L/min (50% N(2)O in O(2)) and fentanyl (2 microg/kg). All patients received patient-controlled analgesia with tramadol with a 50 mg initial loading dose, 20 mg incremental dose, 10-min lockout interval, and 4-h limit of 300 mg. The incremental dose was increased to 30 mg if analgesia was inadequate after 1 h. Patients were studied at 4, 8, 12, 16, 20, and 24 h for visual analog (VAS) pain scores, heart rate, peripheral oxygen saturation, mean arterial blood pressure, respiratory rate, sedation, and tramadol consumption. The VAS scores in the sitting and supine position at 1, 4, 8, 12, 16, and 20 h were significantly lower in the gabapentin group when compared with the placebo group up to 20 h after surgery. The tramadol consumption at 12, 16, 20, and 24 h and total tramadol consumption were significantly less in the gabapentin group when compared with placebo group. Sedation scores were similar at all the measured times. There were no differences between groups in adverse effects. Preoperative oral gabapentin decreased pain scores and postoperative tramadol consumption in patients after abdominal hysterectomy.
This randomized, controlled trial examined the effects of preoperative oral gabapentin 1200 mg on postoperative pain and tramadol consumptions. We conclude that preoperative oral gabapentin is effective in reducing postoperative pain scores and tramadol consumption in patients after abdominal hysterectomy.
在一项随机、安慰剂对照、双盲研究中,我们调查了加巴喷丁对腹部子宫切除术后疼痛及患者曲马多使用量的疗效和安全性。50例患者被随机分为两组,一组在手术前1小时口服安慰剂,另一组口服1200毫克加巴喷丁。采用丙泊酚诱导麻醉,并用七氟醚在50%氧化亚氮/氧气中维持麻醉,新鲜气流为2升/分钟(50%氧化亚氮在氧气中),并给予芬太尼(2微克/千克)。所有患者均接受曲马多患者自控镇痛,初始负荷剂量为50毫克,增量剂量为20毫克,锁定时间间隔为10分钟,4小时限量为300毫克。如果1小时后镇痛效果不佳,增量剂量增加至30毫克。在术后4、8、12、16、20和24小时对患者进行视觉模拟(VAS)疼痛评分、心率、外周血氧饱和度、平均动脉血压、呼吸频率、镇静情况及曲马多使用量的研究。与安慰剂组相比,加巴喷丁组在术后1、4、8、12、16和20小时的坐位和仰卧位VAS评分在术后20小时内显著更低。与安慰剂组相比,加巴喷丁组在术后12、16、20和24小时的曲马多使用量及曲马多总使用量显著更少。在所有测量时间点,镇静评分相似。两组在不良反应方面无差异。腹部子宫切除术后患者术前口服加巴喷丁可降低疼痛评分及术后曲马多使用量。
这项随机对照试验研究了术前口服1200毫克加巴喷丁对术后疼痛和曲马多使用量的影响。我们得出结论,腹部子宫切除术后患者术前口服加巴喷丁可有效降低术后疼痛评分及曲马多使用量。